Enanta Pharmaceuticals Inc (ENTA)
Sales/Maturities of Investments
$267.27M
TTM · Period ending: · USD
ENTA Sales/Maturities of Investments
Latest reported$267.27Mperiod ending
Latest reported$267.27Mperiod ending
ENTA TTM Sales/Maturities of Investments ($35.60M → $267.27M)
TTM Sales/Maturities of Investments
High-resolution chart · PNG
ENTA sales/maturities of investments history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 267,273,000 | |
| 287,415,000 | |
| 286,693,000 | |
| 262,872,000 | |
| 218,520,000 | |
| 254,202,000 | |
| 326,598,000 | |
| 383,465,000 | |
| 474,763,000 | |
| 412,466,999 | |
| 359,285,999 | |
| 328,870,999 | |
| 247,949,999 | |
| 269,454,000 | |
| 223,802,000 | |
| 228,468,000 | |
| 262,183,000 | |
| 300,686,000 | |
| 366,438,000 | |
| 345,089,000 | |
| 346,774,000 | |
| 376,472,000 | |
| 366,497,000 | |
| 359,828,000 | |
| 430,046,000 | |
| 376,344,000 | |
| 449,814,000 | |
| 468,065,000 | |
| 430,748,000 | |
| 410,690,000 | |
| 306,915,000 | |
| 260,682,000 | |
| 204,463,000 | |
| 198,816,000 | |
| 226,582,000 | |
| 249,305,000 | |
| 235,030,000 | |
| 226,797,000 | |
| 197,806,000 | |
| 153,504,000 | |
| 163,687,000 | |
| 156,897,000 | |
| 126,368,000 | |
| 110,617,000 | |
| 86,577,000 | |
| 92,495,000 | |
| 103,769,000 | |
| 99,927,000 | |
| 85,776,000 | |
| 57,913,000 | |
| 43,221,000 | |
| 47,278,000 | |
| 49,879,000 | |
| 47,349,000 | |
| 35,601,000 | |
| 28,700,000 | |
| 25,664,000 |